| {"0": "Sphingolipid metabolism in senescence", "1": "Glycosaminoglycan degradation", "2": "Sphingolipid pathway", "3": "Degradation pathway of sphingolipids including diseases", "4": "Electron transport chain oxphos system in mitochondria", "5": "Metabolism of spingolipids in er and golgi apparatus", "6": "Mitochondrial complex iv assembly", "7": "Mitochondrial complex i assembly model oxphos system", "8": "Type i collagen synthesis in the context of osteogenesis imperfecta", "9": "Metapathway biotransformation phase i and ii", "10": "Oxidative phosphorylation", "11": "Mecp2 and associated rett syndrome", "12": "Nonalcoholic fatty liver disease", "13": "Proteasome degradation", "14": "Overlap between signal transduction pathways contributing to lmna laminopathies", "15": "Influence of laminopathies on wnt signaling", "16": "Mrna processing", "17": "Nuclear receptors metapathway", "18": "Regulation of sister chromatid separation at the metaphaseanaphase transition", "19": "Copper homeostasis", "20": "Cholesterol metabolism with bloch and kandutschrussell pathways", "21": "Translation factors", "22": "Ebola virus infection in host", "23": "Circadian rhythm genes", "24": "Alzheimers disease", "25": "Alzheimers disease and mirna effects", "26": "Folate metabolism"} |